T. Rowe Price Associates’s Puma Biotechnology PBYI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68K | Hold |
19,566
| – | – | ﹤0.01% | 2958 |
|
|
2025
Q1 | $58K | Buy |
19,566
+483
| +3% | +$1.43K | ﹤0.01% | 2906 |
|
|
2024
Q4 | $59K | Buy |
19,083
+5,726
| +43% | +$17.7K | ﹤0.01% | 2904 |
|
|
2024
Q3 | $35K | Hold |
13,357
| – | – | ﹤0.01% | 2962 |
|
|
2024
Q2 | $0 | Buy |
+13,357
| New | – | ﹤0.01% | 3000 |
|
|
2022
Q4 | – | Sell |
-45,400
| Closed | -$108K | – | 2967 |
|
|
2022
Q3 | $108K | Hold |
45,400
| – | – | ﹤0.01% | 2707 |
|
|
2022
Q2 | $129K | Sell |
45,400
-2,868
| -6% | -$8.15K | ﹤0.01% | 2700 |
|
|
2022
Q1 | $139K | Buy |
48,268
+33,900
| +236% | +$97.6K | ﹤0.01% | 2783 |
|
|
2021
Q4 | $44K | Sell |
14,368
-300
| -2% | -$919 | ﹤0.01% | 2928 |
|
|
2021
Q3 | $103K | Hold |
14,668
| – | – | ﹤0.01% | 2835 |
|
|
2021
Q2 | $135K | Buy |
14,668
+643
| +5% | +$5.92K | ﹤0.01% | 2790 |
|
|
2021
Q1 | $136K | Sell |
14,025
-16
| -0.1% | -$155 | ﹤0.01% | 2750 |
|
|
2020
Q4 | $144K | Buy |
+14,041
| New | +$144K | ﹤0.01% | 2589 |
|
|
2020
Q3 | – | Sell |
-905,357
| Closed | -$9.44M | – | 2607 |
|
|
2020
Q2 | $9.44M | Sell |
905,357
-130,254
| -13% | -$1.36M | ﹤0.01% | 1305 |
|
|
2020
Q1 | $8.74M | Buy |
1,035,611
+349,305
| +51% | +$2.95M | ﹤0.01% | 1252 |
|
|
2019
Q4 | $6.01M | Buy |
686,306
+106,335
| +18% | +$930K | ﹤0.01% | 1371 |
|
|
2019
Q3 | $6.24M | Buy |
579,971
+81,362
| +16% | +$876K | ﹤0.01% | 1354 |
|
|
2019
Q2 | $6.34M | Sell |
498,609
-287,356
| -37% | -$3.65M | ﹤0.01% | 1368 |
|
|
2019
Q1 | $30.5M | Buy |
+785,965
| New | +$30.5M | ﹤0.01% | 1040 |
|
|
2018
Q3 | – | Sell |
-4,262
| Closed | -$252K | – | 2587 |
|
|
2018
Q2 | $252K | Buy |
4,262
+83
| +2% | +$4.91K | ﹤0.01% | 2389 |
|
|
2018
Q1 | $284K | Sell |
4,179
-1,972,338
| -100% | -$134M | ﹤0.01% | 2299 |
|
|
2017
Q4 | $195M | Sell |
1,976,517
-3,280,050
| -62% | -$324M | 0.03% | 464 |
|
|
2017
Q3 | $629M | Buy |
5,256,567
+1,822,895
| +53% | +$218M | 0.11% | 205 |
|
|
2017
Q2 | $300M | Buy |
3,433,672
+2,284,727
| +199% | +$200M | 0.05% | 346 |
|
|
2017
Q1 | $42.7M | Buy |
1,148,945
+470,510
| +69% | +$17.5M | 0.01% | 860 |
|
|
2016
Q4 | $20.8M | Sell |
678,435
-253,039
| -27% | -$7.77M | ﹤0.01% | 1129 |
|
|
2016
Q3 | $62.5M | Sell |
931,474
-85,400
| -8% | -$5.73M | 0.01% | 721 |
|
|
2016
Q2 | $30.3M | Sell |
1,016,874
-689,348
| -40% | -$20.5M | 0.01% | 955 |
|
|
2016
Q1 | $50.1M | Sell |
1,706,222
-13,390
| -0.8% | -$393K | 0.01% | 768 |
|
|
2015
Q4 | $135M | Sell |
1,719,612
-11,091
| -0.6% | -$870K | 0.03% | 481 |
|
|
2015
Q3 | $130M | Sell |
1,730,703
-363,744
| -17% | -$27.4M | 0.03% | 511 |
|
|
2015
Q2 | $245M | Sell |
2,094,447
-903,643
| -30% | -$106M | 0.05% | 392 |
|
|
2015
Q1 | $708M | Buy |
2,998,090
+231,389
| +8% | +$54.6M | 0.15% | 172 |
|
|
2014
Q4 | $524M | Sell |
2,766,701
-772,722
| -22% | -$146M | 0.11% | 217 |
|
|
2014
Q3 | $844M | Buy |
3,539,423
+329,056
| +10% | +$78.5M | 0.18% | 141 |
|
|
2014
Q2 | $212M | Buy |
3,210,367
+255,119
| +9% | +$16.8M | 0.05% | 422 |
|
|
2014
Q1 | $308M | Buy |
2,955,248
+8,724
| +0.3% | +$909K | 0.07% | 327 |
|
|
2013
Q4 | $305M | Buy |
2,946,524
+1,590,918
| +117% | +$165M | 0.07% | 323 |
|
|
2013
Q3 | $72.7M | Sell |
1,355,606
-22,961
| -2% | -$1.23M | 0.02% | 679 |
|
|
2013
Q2 | $61.2M | Buy |
+1,378,567
| New | +$61.2M | 0.02% | 716 |
|